glp 1 support groups GLP-1 Strong: Success and Group Insurance companies scrambling to support

Description

Rowlands et al., 2018

Besides being a therapeutic option for type 2 diabetes, semaglutide serves as an anti-obesity drug

DISCLOSURES ABJ has received honoraria for speaking from Abbott, AstraZeneca, Boehringer Ingelheim, Dexcom, Eli Lilly, Janssen, Merck, Novo Nordisk and Sanofi, and has been involved in advisory boards for Abbott, AstraZeneca, Boehringer Ingelheim, Dexcom, Eli Lilly, Novo Nordisk and Sanofi

Formulary Tier Placement When GLP-1s are covered: Often placed on highest formulary tiers (Tier 4-5: "Specialty" or "Non-Preferred Brand") Results in highest copays or coinsurance percentages May have additional utilization management requirements Insurance Coverage Success Rates and Realistic Expectations According to industry data and telehealth platform reports: Coverage Likelihood by Insurance Type : Commercial Insurance (Employer-Sponsored or Marketplace) : Coverage Probability : Moderate to Low (estimates vary 20-40% of commercial plans cover GLP-1s for weight loss) Factors Affecting Coverage : Employer size and plan generosity (large employers more likely to cover) Industry sector (healthcare, technology sectors often more generous) Plan premium level (platinum/gold plans more likely than bronze/silver) State mandates (some states require coverage